Huaren Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Huaren Pharmaceutical has a total shareholder equity of CN¥2.8B and total debt of CN¥986.7M, which brings its debt-to-equity ratio to 34.8%. Its total assets and total liabilities are CN¥4.9B and CN¥2.0B respectively. Huaren Pharmaceutical's EBIT is CN¥305.8M making its interest coverage ratio 5.9. It has cash and short-term investments of CN¥120.1M.
Key information
34.8%
Debt to equity ratio
CN¥986.74m
Debt
| Interest coverage ratio | 5.9x |
| Cash | CN¥120.10m |
| Equity | CN¥2.84b |
| Total liabilities | CN¥2.04b |
| Total assets | CN¥4.87b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300110's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 300110's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥611.3M).
Debt to Equity History and Analysis
Debt Level: 300110's net debt to equity ratio (30.5%) is considered satisfactory.
Reducing Debt: 300110's debt to equity ratio has increased from 11.2% to 34.8% over the past 5 years.
Debt Coverage: 300110's debt is well covered by operating cash flow (39.9%).
Interest Coverage: 300110's interest payments on its debt are well covered by EBIT (5.9x coverage).